Advertisement

Molecular Biotechnology

, Volume 28, Issue 2, pp 87–95 | Cite as

Construction and characterization of a minimized version of the HIV-1 pNL4-3 plasmid and its application for pseudotyping HIV-1 vectors

  • María Luisa AbadEmail author
  • Tomás Verdura
  • Alicia Vela
  • María José Iglesias
  • Dolores Gutiérrez
  • Manuel Veiga
  • Antonio Aguilera
  • Benito J. Regueiro
Research

Abstract

The pUC-based pNL4-3 plasmid is the most widely used vector for in vitro manipulations of the HIV-1 proviral sequences. We have developed a minimal plasmid (pCHUS) based on pNL4-3, which may be useful to facilitate the design of HIV-based constructions. The strategy that has allowed us to construct pCHUS includes the following steps: (1) pNL-3 digestion by using restriction sites contained within the long terminal repeats (LTRs), (2) recircularization of the fragment containing the pUC18 sequence, (3) amplification of the LTR region restored in the previous step, (4) double digestion of the products obtained in steps 2 and 3, (5) ligation of the fragment containing ColE1+AmpR with the LTR fragment, (6) linearization of the intermediate plasmid obtained, and (7) insertion of the fragment containing the proviral genome into the linearized vector. The pCHUS plasmid includes essential information for its replication and antibiotic selection in bacteria, but it lacks all the unnecessary sequences. Our results suggest that pCHUS may be more advantageous than pNL4-3 for in vitro manipulation of the HIV-1 proviral genome. In addition, we describe a potential application of this new vector for pseudotyping HIV-1 particles, using a single plasmid transfection, as a more helpful alternative to the traditionally used cotransfection method.

Index Entries

HIV-1 retroviral vectors pNL4-3 pCHUS pseudotypes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adachi, A., Gendelman, H. E., Koening, S., et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284–291.PubMedGoogle Scholar
  2. 2.
    Petropoulos, C. J., Parkin, N. T., Limoli, K. L., et al. (2000) A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 44, 920–928.PubMedCrossRefGoogle Scholar
  3. 3.
    Bartz, S. R. and Vodicka, M. A. (1997) Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12, 337–342.PubMedCrossRefGoogle Scholar
  4. 4.
    Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.Google Scholar
  5. 5.
    Ausubel, F. M., Brent, R., Kingston, R. E., et al. (1994) Current Protocols in Molecular Biology. Wiley, New York.Google Scholar
  6. 6.
    Joshi, A. and Jeang, K. (1993) Reduction in growth temperature minimizes instability of large plasmids containing HIV-1 proviral genomes. Biotechniques 14, 882–886.Google Scholar
  7. 7.
    DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., and Calos, M. P. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379–387.PubMedGoogle Scholar
  8. 8.
    Gervaix, A., West, D., Leoni, L. M., Richman, D. D., Wong-Staal, F., and Corbeil, J. (1997) A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl. Acad. Sci. USA 94, 4653–4658.PubMedCrossRefGoogle Scholar
  9. 9.
    Huang, M. T. and Gorman, C. M. (1990) Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18, 937–947.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2004

Authors and Affiliations

  • María Luisa Abad
    • 1
    Email author
  • Tomás Verdura
    • 1
  • Alicia Vela
    • 1
  • María José Iglesias
    • 1
  • Dolores Gutiérrez
  • Manuel Veiga
    • 1
  • Antonio Aguilera
    • 1
  • Benito J. Regueiro
    • 1
  1. 1.Division of Microbiology, Hospital de ConxoComplejo Hospitalario Universitario de Santiago (CHUS)Santiago de CompostelaSpain

Personalised recommendations